The effect of local anesthetics administered via pain pump on chondrocyte viability 34th Annual Meeting of the American-Orthopaedic-Society-for-Sports-Medicine Dragoo, J. L., Korotkova, T., Kanwar, R., Wood, B. SAGE PUBLICATIONS INC. 2008: 1484–88

Abstract

Chondrolysis initiated by postoperative, intra-articular pain pumps has recently been described by multiple institutions.To evaluate the in vitro chondrotoxicity of anesthetic formulations commonly used in pain pumps.Controlled laboratory study.Freshly isolated human articular chondrocytes were cultured for 24-, 48-, and 72-hour trials in a custom bioreactor that mimics the metabolism of synovial fluid. Chondrocytes were perfused in Dulbecco's Modified Eagle's Medium 10% fetal bovine serum and one of the following medications: 1% lidocaine, 1% lidocaine with epinephrine, 0.25% bupivacaine, 0.25% bupivacaine with epinephrine, 0.5% bupivacaine, or 0.5% bupivacaine with epinephrine. Static and perfusion cultures with growth media were used as controls. All experiments were run in duplicate. Live/dead staining was performed, and the ratio of dead:live cells was assessed by fluorescent microscopy and histomorphometry.Significantly more chondrocyte necrosis was found in all cultures with medications containing epinephrine (P < .05) at all time points. Similar necrosis rates were exhibited in 0.25% and 0.5% bupivacaine compared with controls at 24 and 48 hours. However, 0.5% bupivacaine produced significantly more cell death at 72 hours. Similar necrosis rates were exhibited with 1% lidocaine compared to controls at 24 hours.In this in vitro model, 0.25% and 0.5% bupivacaine caused minimal chondrocyte necrosis when used in pain pumps for a maximum of 48 hours. All anesthetics containing epinephrine (pH

View details for DOI 10.1177/0363546508318190

View details for Web of Science ID 000257985900004

View details for PubMedID 18658020